Belinda Pope

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10

Ross Brown, Belinda Pope, Allan G. Murray et al. · Blood · 2001 · 345 citations · Full text

Life Sciences, Cell Biology, Immunology +14

T‐cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells

Maria Raitakari, Ross Brown, Daniel Sze et al. · British Journal of Haematology · 2000 · 70 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Either interleukin‐12 or interferon‐γ can correct the dendritic cell defect induced by transforming growth factor <i>β</i>₁ in patients with myeloma

Ross Brown, Allan G. Murray, Belinda Pope et al. · British Journal of Haematology · 2004 · 58 citations · Full text

Life Sciences, Hematology, Immunology +15

The Labelling Index of Primitive Plasma Cells Determines the Clinical Behaviour of Patients with Myelomatosis

Doug Joshua, Amarette J. Petersen, Ross Brown et al. · British Journal of Haematology · 1996 · 58 citations

Medicine, Hematology, Pathology +16

B7-2–positive myeloma: incidence, clinical characteristics, prognostic significance, and implications for tumor immunotherapy

Belinda Pope, Ross Brown, John Gibson et al. · Blood · 2000 · 58 citations · Full text

Medicine, Hematology, Oncology +14